Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

BLISS GVS PHARMA LTD. - 506197 - Closure of Trading Window

 This is to inform you that pursuant to Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force) and in accordance with the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the Trading window for dealing in securities/shares of Bliss GVS Pharma Limited ('the Company') will remain closed for Insiders, Designated Persons and their immediate relatives of the Company with effect from Saturday, January 01, 2022 until 48 hours after the announcement of the Unaudited financial results of the Company for the quarter ended December 31, 2021.
30-12-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copies of newspaper advertisement of notice published in The Free Press Journal (English) and Navshakti (Regional) on December 22, 2021, concerning the proposed transfer of unclaimed interim dividend 2014-2015 and its corresponding shares to IEPF Authority, pursuant to Section 124(6) of the Companies Act, 2013 read with the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016, as amended from time to time.
22-12-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Notice To Shareholders W.R.T. Transfer Of Unclaimed Interim Dividend 2014-2015 And Its Corresponding Shares To Investor Education And Protection Fund (IEPF) Authority

 In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose copy of the communication sent to those concerned shareholders, whose dividend have remain unclaimed for a period of seven consecutive years or more, concerning the proposed transfer of unclaimed interim dividend 2014-2015 and its corresponding shares to the IEPF Authority in pursuance of section 124(6) of the Companies Act, 2013 read with Rule 6 of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
21-12-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
25-11-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on November 18, 2021 has approved the allotment of 1,69,000 equity shares of face value of Re. 1/- each to the eligible employees who have exercised their stock options under Bliss GVS Pharma Limited-Employee Stock Option Plan 2019 ('Bliss GVS ESOP-2019').
18-11-2021
Bigul

Q2FY22 Quarterly Result Announced for Bliss GVS Pharma Ltd.

 Key Highlights Revenue from Operation Rs 30,745.88 Lakhs EBITDA Rs 5,869.56 Lakhs 19% Revenue from Operation Rs 23,284.38 Lakhs EBITDA Rs 4,498.07 Lakhs 19% Other Income Rs 1388.20 Lakhs Other Income Rs 1013.00 Lakhs PBT Rs 6381.44 Lakhs 20% PBT Rs 4,667.44 Lakh 19% PAT Rs 4,638.54 Lakhs 14% PAT Rs 3,588.33 Lakhs 15% Result PDF
02-11-2021
Bigul

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to the provision of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed clippings of the extract of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on November 01, 2021.
01-11-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Result For The Quarter And Half Yearly Ended September 30, 2021

 We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, October 30, 2021 at the registered office of the Company. In pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Board has considered and approved the matters as per attachment.
30-10-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended And Half Year Ended September 30, 2021

 BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2021 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021. Further, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from October 01, 2021 and shall remain closed till 48 hours after the announcement/declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021. This intimation is also being uploaded on the Company''s website at http://www.blissgvs.com/. Kindly acknowledge and take on record the same.
22-10-2021
Bigul

BLISS GVS PHARMA LTD. - 506197 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that Registrar and Share Transfer Agent of Company M/s. Universal Capital Securities Private Limited has received request for issue of duplicate share certificates consequent to loss of share certificates from the shareholder.
22-10-2021
Next Page
Close

Let's Open Free Demat Account